CLEAR SYNERGY: Benefit–risk of colchicine and spironolactone in acute myocardial infarction: a prespecified generalised pairwise comparisons analysis of the CLEAR trial

Heart

d'Entremont MA, Jolly SS, Alharthi F, Shah B, Austin D, Yi Q, Storey RF, Bossard M, Cornel J, Jaspers Focks J, Kedev S, Asani V, Stankovic G, Tsang M, Valettas N, Tyrwhitt J, Betz J, Lee SF, Mian R, Silvain J, Beygui F, Czarnecki A, Dehghani P, Cantor W, Lavi S, Spratt JC, Belley-Côté EP, Eikelboom JW.

September 2025

Read More

PURE: Ultraprocessed Grains and Risk of Inflammatory Bowel Disease

The American Journal of Gastroenterology

Narula N, Wong ECL, Mente A, Rangarajan S, Lang X, Li Q, Chen M, Mohan I, Mat-Nasir N, Diaz ML, Lopez-Jaramillo P, Bahonar A, Avezum A, Karsidag K, Rosengren A, Abat MEM, Lanas F, Swart EC, Yusuf R, Alhabib KF, Iqbal R, Basiak-Rasała A, Khatib R, Yusufali A, Yeates K, Chifamba J, Marshall JK, Moayyedi P, Reinisch W, Yusuf S.

August 2025

Read More

COMPASS MIND: Atrial fibrillation and atherosclerosis cause different vascular brain lesions on magnetic resonance imaging

European Heart Journal

Stegmann T, Joundi RA, Srivastava A, Sinnecker T, Aeschbacher S, Eikelboom JW, Wachter R, Smith EE, Rodondi N, Bosch J, Blum MR, Connolly SJ, Beer JH, Reeh KW, Reichlin T, Lonn EM, Yi Q, Müller AS, Branch KRH, Di Valentino M, Avezum A, Fox KAA, Ammann P, Bonati LH, Moschovitis G, Krisai P, Kühne M, Osswald S, Sharma M, Conen D.

September 2025

Read More

ACHIEVE: Spironolactone versus placebo in patients undergoing maintenance dialysis: an international, parallel-group, randomised controlled trial

The Lancet

Walsh M, Collister D, Gallagher M, Mark PB, de Zoysa JR, Tyrwhitt J, Tennankore K, Reis G, Xavier D, Liu WJ, Zuo L, Wang AY, Félix C, Sola L, Arici M, Villanueva R, Jha V, Précoma D, Rabbat CG, Alavudeen SS, Faruqui AR, López-Flecher M, Pyne L, Wald R, Yuan F, Balasubramanian K, Lee SF, Kuptsova A, Christou C, Devereaux PJ

August 2025

Read More

Back To Top